Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 436 AL 450

Forcible Geste Antagoniste as a Transdiagnostic Feature in Severe Jaw-Opening Dystonia

Zaheer SS, Heim B, Lang AE, Ganos C.

Mov Disord Clin Pract. 2026 Oct 27:10.1002/mdc3.70869. doi: 10.1002/mdc3.70869. Online ahead of print.

Upper Extremity Motor Performance During a Shirt Buttoning Task in Huntington's Disease

Simón-Vicente L, Cuesta-García C, Calvo S, Mariscal N, Saiz-Rodríguez M, Aguado L, Muñoz-Siscart I, De la Cruz Salamanca I, Díaz-Piñeiro D, Cubo E.

OTJR (Thorofare N J). 2026 Oct;46(4):709-718. doi: 10.1177/15394492251355942. Epub 2025 Aug 16.

Delayed-Onset Acute Chorea Following Anesthesia

Tekin HG, Hür Ö, Kuşgöz F, İncecik F.

J Child Neurol. 2026 Oct;41(9):1340-1343. doi: 10.1177/08830738261420286. Epub 2026 Feb 16.

Plant-based models of neurodegenerative CAG repeat expansion diseases

Saravanan M, Kittur FS, Xie J.

Trends Biotechnol. 2026 Oct;44(10):2831-2834. doi: 10.1016/j.tibtech.2026.01.003. Epub 2026 Mar 14.

Mechanisms underlying rheumatic heart disease immune-mediated pathogenesis: T-cell responses, cytokine networks, and immune dysregulation as drivers of valvular injury

Lupieri A, Diaz JM, Moreira TB, Jacaúna A, McCormick JK, Nizet V, Levine RA, Aikawa E, Dutra WO; Leducq PRIMA (Preventing Rheumatic Injury bioMarker Alliance) Network.

Lancet Microbe. 2026 Oct;7(10):101499. doi: 10.1016/j.lanmic.2026.101499. Epub 2026 Sep 1.

Perspectives on Psychiatric Features of Sydenham Chorea

Mendelman L, Dale RC, Mackenzie K, Bostwick JM, Wald ER, Sanger T, Miles K, Kendell S, Pasternack MS, Frankovich J.

Pediatrics. 2026 Oct 1;158(4):e2026076410. doi: 10.1542/peds.2026-076410.

Effects of time-restricted eating in early-stage Huntington's disease: a pilot study

Wells RG, Neilson LE, McHill AW, Gray NE, Quinn JF, Hiller AL.

Nat Metab. 2026 Oct;8(10):2060-2068. doi: 10.1038/s42255-026-01612-x. Epub 2026 Sep 17.

Uncovering hidden protein networks in Huntington's disease: implications for pathogenesis and therapy

Panwar C, Goel F, Garg VK.

Mol Biol Rep. 2026 Sep 27;53(1):1626. doi: 10.1007/s11033-026-12823-6.

Planning advanced therapy trials for Huntington's disease: Ethical considerations

Towns C, Ballantyne A, Konstantinova P, Drew C, Rosser A.

Mol Ther. 2026 Sep 28:S1525-0016(26)00802-6. doi: 10.1016/j.ymthe.2026.09.035. Online ahead of print.

Estrogen and progesterone receptor signaling as candidate neuroendocrine modulators in Huntington's disease

Carlson J.

Neurodegener Dis Manag. 2026 Sep 29:1-13. doi: 10.1080/17582024.2026.2739334. Online ahead of print.

Chaperone-mediated remodelling of mutant huntingtin

Gharat K, Kirstein J.

Philos Trans R Soc Lond B Biol Sci. 2026 Oct 1;381(1960):20250269. doi: 10.1098/rstb.2025.0269.

Mechanistic Differences in Adult-Onset and Juvenile-Onset Huntington's Disease and the Potential Role of Neurodevelopment

Anjur Thupil V, Satchidanand N.

Cureus. 2026 Sep 29;18(9):e117175. doi: 10.7759/cureus.117175. eCollection 2026 Sep.

From Design to Bedside: Brain-Targeted Engineered Nanoparticles and Predictive Modeling for Neurodegenerative Diseases Therapeutics

Nguyen N, Yuan M, Wang Y.

Pharm Res. 2026 Oct 1. doi: 10.1007/s11095-026-04201-5. Online ahead of print.

Acidic cannabinoids in brain disorders: Neurobiological mechanisms, preclinical evidence, and translational challenges

Rava A, Di Trapano M, Tse C, Ji L, Bid HK, Trezza V.

Neurosci Biobehav Rev. 2026 Dec;191:107005. doi: 10.1016/j.neubiorev.2026.107005. Epub 2026 Oct 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias